Abstract:Purpose: Sexually transmitted infections (STIs) represent an enormous public health burden in the United States. Emergency departments (EDs) are a significant source of medical care, particularly for vulnerable patient populations. Guidelines for the treatment of Chlamydia trachomatis have evolved and now recommend doxycycline 100 mg orally twice daily for 7 days as the primary regimen for adults. However, the single-dose azithromycin regimen can be given during the ED visit, while the new regimen has nonadherence hurdles. The purpose of this study will be determining the rate of ED discharge prescription pick ups of doxycycline for Chlamydia trachomatis infection at two discharge pharmacies. Methods: This is a retrospective chart review of information contained in the electronic medical record (EMR) from August 1st, 2021 - July 31st, 2022. Adult patients who present to the two EDs in the healthcare system and those who received empiric antibiotic treatment for Chlamydia trachomatis infection prior to, or at, ED discharge will be included. Patients who are pregnant, less than 18 years old, those without a Chlamydia trachomatis nucleic acid amplification test during their ED visit, or patients whose antibiotic treatment prescription was sent to a pharmacy other than the two primary discharge pharmacies at the respective medical centers will be excluded. The primary outcome of this study will be determining the rate of emergency department (ED) discharge prescription pick ups of doxycycline for empiric treatment of Chlamydia trachomatis infection at two discharge pharmacies. The secondary outcomes will include the incidence of repeat positive tests between four weeks and 90 days, risk of repeat positive tests in those who do not fill doxycycline, number of positive and negative test results, rate of prescribing adherence to 2021 Centers for Disease Control and Prevention (CDC) Sexually Transmitted Infections Treatment Guidelines regimens for empiric treatment, and insurance status at the time of discharge fill. Results: Seven hundred and thirty patients were pulled from the EMR. One hundred of the patients were excluded from the study as they did not receive empiric antibiotic treatment for Chlamydia trachomatis infection prior to, or at, ED discharge leaving 630 participants. Among this group, 369 patients were excluded as their discharge prescription was not sent to the discharge pharmacies within the medical system, leaving 261 individuals in the study. Per chart review, 215 of the patients picked up their doxycycline prescription (82.4%) and 46 (17.6%) patients failed to pick up their prescription. Additionally, 43 (16.5) of the patients who were prescribed empiric therapy had a positive chlamydia trachomatis test, while 209 (83.5%) of those had a negative test. This study also showed 188 (72%) patients received treatment according to the current CDC recommendations. Conclusion: Majority of patients who received prescriptions from the in-hospital discharge pharmacy picked up their prescriptions.

155. Acceptance and Implementation of 2021 CDC Guidelines for Treatment of Uncomplicated Urogenital Chlamydial Infections by Adolescent Medicine Providers

Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020

Doxycycline adherence for the management of Chlamydia trachomatis infections

Impact of the CDC 2021 Sexually Transmitted Infection Guideline Update on Emergency Medicine

Analysis of Patient Adherence to Filling Emergency Department Discharge Prescriptions for Empiric Treatment of Chlamydia

115. Rates of Reinfection for Trichomonas vaginalis in Adolescents and Young adults: an Assessment Following the CDC STI Treatment Guidelines in 2021

Trends in Chlamydia trachomatis Treatment Prescribing Practices in King County, Washington, 2010 - 2018

Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women.

CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024

Adolescent Chlamydia Screening in Pediatric Primary Care: A Quality Improvement Project

Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure)

Patient-delivered partner therapy for chlamydia: health practitioner views on updated guidance in Victoria, Australia

Treatment Rates for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) in a Metropolitan Area: Observational Cohort Analysis

Filling in the Gaps: Updates on Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections

Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis

Doxycycline Compared with Azithromycin for Treating Women with Genital Chlamydia trachomatis Infections: An Incremental Cost-Effectiveness Analysis

Pharmacokinetics of single dose doxycycline in the rectum, vagina, and urethra: implications for prevention of bacterial sexually transmitted infections

Executive Summary: International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

Chlamydia trachomatis Infections: Progress and Problems

Concordance of Outpatient Antibiotic Prescribing with Infectious Diseases Society of America (IDSA) Guidelines for the Treatment of Acute Uncomplicated Cystitis in Southern Maine

190. Identifying Provider Attitudes, Practices, and Barriers to Three-Point Extra-Genital Testing for Neisseria Gonorrhea and Chlamydia Trachomatis Infections Among Adolescents and Young Adults